BINDER HAGIT enters NEUROSENSE THERAPEUTICS LTD. with 321.81K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 3/18/2026ACC: 0001213900-26-030597
Officer· General Manager
Since Mar 2026
321.81K
Baseline shares
100% direct
321.81K
Direct ownership
4 positions
36K
Derivative underlying
1 instrument
4
Security positions
All direct
Non-Derivative Holdings4
Ordinary Shares
DirectShares owned12.84K
Ordinary Shares
DirectShares owned266.97K
Restricted Share Units
DirectShares owned10K
Ordinary Shares
DirectShares owned32K
Total
321.81K direct321.81K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 12.84K | Direct |
| Ordinary Shares | 266.97K | Direct |
| Restricted Share Units | 10K | Direct |
| Ordinary Shares | 32K | Direct |
| Total | 321.81K | 321.81K direct |
Derivative Holdings1
Options to Purchase Ordinary Shares
DirectUnderlying security
Ordinary Shares
Underlying shares
36K
Shares owned
N/A
Exercise price
1.99
Expiration
—
Exercise window
—
Total
Underlying
36K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options to Purchase Ordinary Shares Direct | Ordinary Shares | 1.99 | — | — | 36K | N/A |
| Total | 36K | 0.00 | ||||